Amicus Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
FOLD on Nasdaq
Industry
Pharmaceutical Preparations
Location
47 Hulfish Street, Princeton, NJ

Insiders trading volume in the past year

Amicus Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradley L. Campbell President and CEO, Director $11.4M -$297K -2.54% Dec 1, 2025
John F. Crowley Executive Chairman, Director $8.52M Mar 1, 2024
Ellen Rosenberg Chief Legal Officer $5.21M -$958K -15.5% Nov 24, 2025
Daphne Quimi Chief Financial Officer $4.93M Jan 17, 2023
Jeff Castelli Chief Development Officer $4.46M -$774K -14.8% Nov 24, 2025
David Michael Clark Chief People Officer $3M -$503K -14.4% Nov 24, 2025
Simon N.R. Harford Chief Financial Officer $1.63M Aug 21, 2025
Samantha Prout Chief Accounting Officer $1.26M Dec 1, 2025
Burke W. Whitman Director $736K Jun 5, 2025
Glenn Sblendorio Director $719K Jun 5, 2025
Michael Raab Director $719K Jun 5, 2025
Lynn Dorsey Bleil Director $708K Jun 5, 2025
Margaret G. Mcglynn Director $569K Jun 5, 2025
Craig A. Wheeler Director $526K Jun 5, 2025
Eiry Roberts Director $474K Jun 5, 2025
Michael Aaron Kelly Director $450K Jun 5, 2025
Robert Essner Director $385K Jun 10, 2021

Recent Insider Transactions by Companies or Individuals for Amicus Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.